Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies

  • Philipp A. Ilinykh
  • , Kai Huang
  • , Rodrigo I. Santos
  • , Pavlo Gilchuk
  • , Bronwyn M. Gunn
  • , Marcus M. Karim
  • , Jenny Liang
  • , Mallorie E. Fouch
  • , Edgar Davidson
  • , Diptiben V. Parekh
  • , James Kimble
  • , Colette A. Pietzsch
  • , Michelle Meyer
  • , Natalia A. Kuzmina
  • , Larry Zeitlin
  • , Erica Ollmann Saphire
  • , Galit Alter
  • , James E. Crowe
  • , Alexander Bukreyev

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Ilinykh et al. analyzed antibodies from a human survivor of Marburg virus infection and discovered biological properties for non-neutralizing antibodies that protect animals from lethal Marburg virus infection. These include inducing strong Fc domain-mediated effector functions and structural glycoprotein rearrangements that facilitate access of neutralizing antibodies to their recognition sites.

Original languageEnglish (US)
Pages (from-to)976-991.e11
JournalCell Host and Microbe
Volume27
Issue number6
DOIs
StatePublished - Jun 10 2020

Keywords

  • Fc-mediated protective effects
  • Marburg virus
  • animal models of filovirus infection
  • antibodies
  • cooperativity of antibody binding
  • glycoprotein

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Virology

Fingerprint

Dive into the research topics of 'Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies'. Together they form a unique fingerprint.

Cite this